MRI for Metastatic Brain Tumors

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Metastatic Brain TumorsMRI - Other
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test whether adding an MRI sequence can help doctors better distinguish between radiation damage and tumor recurrence in patients who have had brain radiation surgery.

Eligible Conditions
  • Metastatic Brain Tumors

Treatment Effectiveness

Study Objectives

2 Primary · 0 Secondary · Reporting Duration: baseline

baseline
number of negative MRI sequences along with negative tumor biopsies
number of positive MRI sequences along with positive tumor biopsies

Trial Safety

Trial Design

1 Treatment Group

MRI
1 of 1

Experimental Treatment

37 Total Participants · 1 Treatment Group

Primary Treatment: MRI · No Placebo Group · N/A

MRI
Other
Experimental Group · 1 Intervention: MRI · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline

Who is running the clinical trial?

Duke UniversityLead Sponsor
2,179 Previous Clinical Trials
3,200,677 Total Patients Enrolled
Scott Floyd, M.D. Ph.D.Principal InvestigatorDuke Health

Eligibility Criteria

Age 18+ · All Participants · 7 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are a candidate for LITT procedure as determined by a neurosurgeon and/or anesthesia team.
You are an adult patient.
You have received WBRT for brain metastatic disease.
You have metastatic malignancy with at least 1 brain metastasis previously treated with stereotactic body radiotherapy.